ディスルフィラムは,バルビタルの薬理学的活性を増強し,その尿経排泄を阻害する
まとめ
ディスルフィラムは,バルビタルを有意に増加させた.
科学分野:
- 薬理学 薬理学とは
- 毒理学 毒理学 毒理学
- 薬物の代謝について
背景:
- ディスルフィラムはアルコール依存症の治療に使用されます.
- バービタルは鎮静催眠薬です.
研究 の 目的:
- ネズミのバルビタル誘発睡眠に対するディスルフィラムの効果を調査する.
- ディスルフィラムとバービタルとの間の薬理学的な相互作用を解明するために.
主な方法:
- ネズミにバルビタルは単独またはディスルフィラームと併用して投与された.
- 血液と脳組織におけるバービタル濃度が測定されました.
- バルビタルの尿による排泄量は定量化されました.
主要な成果:
- ディスルフィラムは,ラットにおけるバービタル誘発睡眠時間を著しく延長した.
- バービタル濃度は,ジスルフィラムを投与されたラットの血液と脳で有意に高かった.
- バルビタルの尿による排泄は,ジスルフィラムを投与したラットで有意に減少した.
結論:
- ディスルフィラムは,バルビタルの代謝または排泄を阻害する.
- この相互作用は,バービタル濃度の上昇と長期的効果につながる可能性があります.
- ディスルフィラムとバービタルを併用する際には注意が必要です.
関連する概念動画
Drug Elimination by Renal Route: Tubular Reabsorption
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
Enhanced Elimination of Poison
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...


